NCT03613428 2018-08-03Ruxolitinib Plus LVP in Patients With R/R ETP-ALLSichuan UniversityPhase 1/2 Unknown12 enrolled
NCT00363090 2013-09-20Alemtuzumab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV T-Cell Non-Hodgkin's LymphomaNational Cancer Institute (NCI)Phase 1/2 Unknown84 enrolled